AK5-21592-51270
2 vaccinations
3 coded responses
6 check-ins
3 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 173 / PA
- Registered
- 2021-01-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-14
Dose 1 — Pfizer-BioNTech
-
2021-01-19
Registered in v-safe
-
2021-01-19
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness · Fatigue or tirednessAdult check-in
- 2021-01-22
-
2021-01-30
Survey response — day 14, dose 1MedDRA: Full blood count abnormal, White blood cell count abnormal, White blood cell count decreased — Feeling: GoodFree text: CBC today showed all values lower than last month. I Expect Hgb to be lower but most all of white blood cells are low, several below normal range.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-04
Dose 2 — Pfizer-BioNTech
- 2021-02-18
-
2021-03-01
Survey response — day 21, dose 2MedDRA: Unevaluable event — Feeling: GoodFree text: Appears that I may be passing more protein in my urine. Will have a complete metabolic panel drawn on 8 March at John Hopkins.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-08-07
Survey response — 6 months, dose 2MedDRA: Eye pain, Periorbital pain, Vision blurred — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Pain close around eyes when focus close especially in dim light. Often noticeably painful moving eye to look up or down while focusing. Seems muscular.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-07
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-12-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Pfizer-BioNTech | |
| 2 | 2021-02-04 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 3 — day 14, dose 1
Symptoms: CBC today showed all values lower than last month. I Expect Hgb to be lower but most all of white blood cells are low, several below normal range.
Release 4 — day 21, dose 2
Symptoms: Appears that I may be passing more protein in my urine. Will have a complete metabolic panel drawn on 8 March at John Hopkins.
Release 9 — 6 months, dose 2
Symptoms: Pain close around eyes when focus close especially in dim light. Often noticeably painful moving eye to look up or down while focusing. Seems muscular.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Eye pain | ✓ | · | ✓ |
| SD | Full blood count abnormal | ✓ | ✓ | ✓ |
| SD | Periorbital pain | ✓ | · | ✓ |
| SD | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Vision blurred | ✓ | · | ✓ |
| SD | White blood cell count abnormal | ○ | ✓ | ○ |
| SD | White blood cell count decreased | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release